
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin.
from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/G6rVI0s
Comments
Post a Comment